Hikma Pharmaceuticals PLC (HIK)
Market Closed
15 Jun, 20:00
€
192. 00
-4
-2.0408%
€
- Market Cap
12.23 P/E Ratio
612% Div Yield
200 Volume
0 Eps
€ 196
Previous Close Want to track HIK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hikma Pharmaceuticals PLC (HIK) Statistics
Valuation metrics
Market Cap -
Enterprise value 464.05B
Trailing P/E (ttm) 0.08
Forward P/E -
PEG ratio -0.04
Price/Sales (ttm) -
Price/Book (mrq) 0.01
Enterprise Value/Revenue 0.68
Enterprise Value/EBITDA 2.57
Overview
Shares outstanding 43.92M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 21
Average volume (90 days) 7
Price summary
52-Week low 181
52-Week high 252
Beta -
50-Day moving average 215.26
200-Day moving average 228.34
Dividends and splits
Forward annual dividend rate 4.22
Forward annual dividend yield 0.0207%
Trailing annual dividend rate 4.06
Trailing annual dividend yield 0.0199%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Mar 2026
Ex-Dividend Date 29 Dec 2025
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.5%
Operating margin 0.24%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.12%
Income Statement
Revenue (ttm) 686.55B
Revenue per share (ttm) 15,604.66
Quarterly revenue growth (yoy) -
Gross profit (ttm) 343.3B
EBITDA 180.66B
Net income to common (ttm) 117.52B
Diluted EPS (ttm) 2,667.29
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 977.14B
Total Debt/Equity (mrq) 0.9
Current ratio (mrq) 1.7%
Book value per share (mrq) 24,876.02
Cash Flow
Cash flow statement 61.74B
Levered free cash flow (LFCF) 117.52B
